日本基于临床的睑板腺功能障碍研究
在日本一家眼科医院对50岁及以上拟行白内障手术的连续患者进行睑板腺功能障碍(MGD)患病率研究,采用与西班牙白人人群研究相同的诊断标准。共纳入510例患者,有症状MGD患病率为11.2%,总MGD患病率为74.5%,总MGD患病率随年龄增长显著增加(P < 0.0001)。作者结论认为,基于本诊断标准,东京的MGD患病率高于西班牙人群。
要点
- 50岁及以上拟行白内障手术患者中,总MGD患病率为74.5%,有症状MGD患病率为11.2%。
- 总MGD患病率随年龄增长显著增加(P < 0.0001)。
- MGD阳性与阴性患者间男女比例及任何系统性疾病患病率无差异。
核心结论
- 基于本诊断标准,东京的MGD患病率高于西班牙人群。
研究设计与样本
- 在日本Inouye Eye Hospital对拟行白内障手术的连续患者进行的临床研究,采用与既往西班牙白人人群研究相同的诊断标准。
- 共纳入510例患者(男205例、女305例),平均年龄71.1 ± 8.5岁(范围50-93岁),所有参与者年龄50岁及以上。
- 患者完成症状问卷并接受全面裂隙灯检查;MGD诊断为至少一眼存在以下一项或多项:数字压迫后无分泌物、黏稠或蜡样白色分泌物;存在2条及以上睑缘毛细血管扩张;和/或2个及以上腺体开口阻塞。
主要发现
- 有症状MGD患病率为11.2%,总MGD(有症状MGD+无症状MGD)患病率为74.5%。
- 总MGD患病率随参与者年龄增加而显著增加(P < 0.0001)。
- MGD阳性与阴性患者间男女比例及任何系统性疾病患病率无差异。
- 总MGD组较非MGD患者所有裂隙灯表现更频繁、荧光素评分更高、泪膜破裂时间更短、meibo评分更大。
关键数值与推荐
- MGD诊断标准:至少一眼存在以下一项或多项:数字压迫后无分泌物、黏稠或蜡样白色分泌物;存在2条及以上睑缘毛细血管扩张;和/或2个及以上腺体开口阻塞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the prevalence of meibomian gland dysfunction (MGD) in the Japanese population. METHODS: We undertook a clinical study on the prevalence of MGD in Japan using the same diagnostic criteria as a previous population-based study conducted in Spanish Caucasians. The participants were consecutive patients scheduled for cataract surgery at Inouye Eye Hospital. All participants were aged 50 years or older. Patients completed a symptoms questionnaire and underwent a comprehensive slit-lamp examination. Meibomian gland dysfunction was diagnosed when one or more of the following was present in at least in one eye: absent, viscous, or waxy white secretion upon digital expression; presence of two or more lid margin telangiectases; and/or plugging of two or more gland orifices. RESULTS: The study included 510 patients (205 men and 305 women). Mean participant age was 71.1 ± 8.5 years (range, 50-93 years). The prevalences of symptomatic and total MGD (symptomatic MGD + asymptomatic MGD) were 11.2% and 74.5%, respectively. The prevalence of total MGD increased significantly as participant age increased (P < 0.0001). The ratio of males to females and the prevalence of any systemic disease did not differ between patients who were positive or negative for MGD. For the total MGD group, all slit-lamp findings were more frequent, fluorescein score was higher, tear film breakup time was shorter, and meibo-score was larger, compared to non-MGD patients. CONCLUSIONS: Based on the present diagnostic criteria, prevalence of MGD is higher in Tokyo, compared to the Spanish population.
引用
- Amano S, Inoue K. Clinic-Based Study on Meibomian Gland Dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017. PMID: 28241316. doi:10.1167/iovs.16-21374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。